Christina Coughlin
Tracked across 2 events · 13 articles · First seen Jul 08, 2026 · Last active Sep 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Christina Coughlin, CEO of Avacta, welcomed the appointment.
Jul 08, 2026 · 6 articles
Business
Avacta Group Therapeutics, a clinical-stage biopharmaceutical company listed on AIM under ticker AVCT, announced on September 14, 2026 the appointment of seasoned biotechnology finance executive Mats Blom to its Board of Directors as a non-executive…
Impact: Avacta Group CEO who welcomed Blom's appointment, highlighting his financial expertise as instrumental to advancing the pre|CISION platform and strategic milestones.
Sep 14, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Christina Coughlin live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard